These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33841331)

  • 1. Association Between Lipoprotein (A) and Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis.
    Ren X; Zhang Z; Yan Z
    Front Endocrinol (Lausanne); 2021; 12():633529. PubMed ID: 33841331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus.
    Senba H; Furukawa S; Sakai T; Niiya T; Miyake T; Yamamoto S; Ueda T; Torisu M; Minami H; Miyaoka H; Onji M; Tanaka K; Matsuura B; Tanigawa T; Hiasa Y; Miyake Y
    J Diabetes Complications; 2016 Jul; 30(5):923-7. PubMed ID: 26947887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria.
    Song KH; Ko SH; Kim HW; Ahn YB; Lee JM; Son HS; Yoon KH; Cha BY; Lee KW; Son HY
    Diabetes Care; 2005 Jul; 28(7):1718-23. PubMed ID: 15983325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study.
    Moosaie F; Firouzabadi FD; Abouhamzeh K; Esteghamati S; Meysamie A; Rabizadeh S; Nakhjavani M; Esteghamati A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1723-1731. PubMed ID: 32636121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Lipoprotein(a) and diabetic nephropathy in patients with type 2 diabetes.
    Li M; Wang Y; Yao Q; Liang Q; Zhang Y; Wang X; Li Q; Qiang W; Yang J; Shi B; He M
    Front Endocrinol (Lausanne); 2023; 14():1337469. PubMed ID: 38288472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between lipoprotein(a) plasma levels and diabetic nephropathy in Han Chinese patients with type 2 diabetes mellitus.
    Wang T
    PLoS One; 2024; 19(5):e0299240. PubMed ID: 38743736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) in diabetes mellitus.
    Ritter MM; Loscar M; Richter WO; Schwandt P
    Clin Chim Acta; 1993 Jan; 214(1):45-54. PubMed ID: 8453777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
    Qiao YC; Chen YL; Pan YH; Ling W; Tian F; Zhang XX; Zhao HL
    Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) is not significantly associated with type 2 diabetes mellitus: cross-sectional study of 1604 cases and 7983 controls.
    Liu C; Xu MX; He YM; Zhao X; Du XJ; Yang XJ
    Acta Diabetol; 2017 May; 54(5):443-453. PubMed ID: 28132096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Serum Irisin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis.
    Wang R; Liu H
    Horm Metab Res; 2021 May; 53(5):293-300. PubMed ID: 33962476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the stage of diabetic nephropathy and serum lipoprotein (a) concentrations--influence of hypoproteinemia].
    Nakagawa H; Kida Y; Sakamoto K; Haneda M; Kikkawa R
    Nihon Jinzo Gakkai Shi; 1996 Nov; 38(11):513-8. PubMed ID: 8958706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of lipoprotein(a) and its phenotypes with the albumin excretion rate in diabetic patients: a multivariate analysis.
    Hernández C; Chacón P; Martí R; García-Pascual L; Mesa J; Simó R
    Nephron; 2000 May; 85(1):27-33. PubMed ID: 10773752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study.
    Zhang Y; Jin JL; Cao YX; Zhang HW; Guo YL; Wu NQ; Zhu CG; Gao Y; Hua Q; Li YF; Xu RX; Li JJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):111. PubMed ID: 32646432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients.
    Clodi M; Oberbauer R; Bodlaj G; Hofmann J; Maurer G; Kostner K
    Metabolism; 1999 Mar; 48(3):369-72. PubMed ID: 10094115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipoprotein(a) concentration as a cardiovascular risk factor in Kuwaiti type 2 diabetic patients.
    Abdella NA; Mojiminiyi OA; Akanji AO; Al Mohammadi H; Moussa MA
    J Diabetes Complications; 2001; 15(5):270-6. PubMed ID: 11522503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus.
    Wakabayashi I; Masuda H
    Clin Chim Acta; 2006 Nov; 373(1-2):127-31. PubMed ID: 16820145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
    Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
    Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
    Tarkun I; Cetinarslan B; Cantürk Z
    Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients.
    Saely CH; Koch L; Schmid F; Marte T; Aczel S; Langer P; Hoefle G; Drexel H
    Eur J Clin Invest; 2006 Feb; 36(2):91-7. PubMed ID: 16436090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.